Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000908658 | SCV001053435 | likely benign | not provided | 2018-05-03 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002495489 | SCV002800350 | likely benign | Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2; Hydrocephalus, congenital, 3, with brain anomalies | 2021-07-28 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000908658 | SCV005217911 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Ce |
RCV000908658 | SCV005330914 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | WDR81: BP4 |
Prevention |
RCV004551767 | SCV004780577 | likely benign | WDR81-related disorder | 2024-08-24 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |